Reactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it.

1. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.Rheumatology international · 2019
   Guideline
2. Risk of Hepatitis B Virus Reactivation in Patients With Inflammatory Arthritis Receiving Disease-Modifying Antirheumatic Drugs: A Systematic Review and Meta-Analysis.Arthritis care & research · 2018
   Pooled it
3. Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis.Annals of internal medicine · 2016
   Pooled it
4. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.The Pediatric infectious disease journal · 2013
   Guideline
5. Evaluation of hepatitis B virus reactivation prevention measures in immunosuppressed patients: current status and effectiveness.Translational gastroenterology and hepatology · 2025
   Article
6. Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness.Clinical journal of gastroenterology · 2024
   Article
7. Electronic Alert System Significantly Increases HBV Screening Rates Before Immunosuppressive Treatments.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
   Article
8. COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature.Pathogens (Basel, Switzerland) · 2022
   Review
9. Screening for Hepatitis B Virus Prior to Initiating Tocilizumab and Tofacitinib in Patients With Rheumatic Diseases: A Cross-sectional Study.The Journal of rheumatology · 2022
   Article
10. Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.Digestive diseases and sciences · 2021
    Article
11. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.World journal of gastroenterology · 2021
    Review
12. Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus.Journal of Korean medical science · 2021
    Article
13. [Progress in the research of HBV reactivation in patients undergoing hematopoietic stem cell transplantation].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2021
    Article
14. RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs.Seminars in arthritis and rheumatism · 2020
    Article
15. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention.World journal of gastroenterology · 2019
    Review
16. Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.Cancer medicine · 2018
    Article
17. Recent Advances in HBV Reactivation Research.BioMed research international · 2018
    Review
18. Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.Hepatology (Baltimore, Md.) · 2018
    Observational
19. Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Gastroenterology · 2017
    Review
20. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.Blood · 2017
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as